Latest Insider Transactions at Processa Pharmaceuticals, Inc. (PCSA)
This section provides a real-time view of insider transactions for Processa Pharmaceuticals, Inc. (PCSA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Processa Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Processa Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 10
2024
|
James H Stanker Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
282
-4.17%
|
$282
$1.71 P/Share
|
|
Jul 10
2024
|
James H Stanker Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
644
+8.69%
|
-
|
|
Jul 10
2024
|
Sian Bigora Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
225
-1.02%
|
$225
$1.71 P/Share
|
|
Jul 10
2024
|
Sian Bigora Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
644
+2.83%
|
-
|
|
Jul 10
2024
|
Patrick Lin Chief Business - Strategy Off |
SELL
Payment of exercise price or tax liability
|
Direct |
271
-0.92%
|
$271
$1.71 P/Share
|
|
Jul 10
2024
|
Patrick Lin Chief Business - Strategy Off |
BUY
Exercise of conversion of derivative security
|
Direct |
644
+2.15%
|
-
|
|
Jul 10
2024
|
David Young Pres. Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
282
-0.35%
|
$282
$1.71 P/Share
|
|
Jul 10
2024
|
David Young Pres. Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
644
+0.79%
|
-
|
|
Jul 10
2024
|
Wendy Guy Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
220
-1.82%
|
$220
$1.71 P/Share
|
|
Jul 10
2024
|
Wendy Guy Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
644
+5.06%
|
-
|
|
Apr 05
2024
|
James H Stanker Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
518
-7.8%
|
$1,036
$2.79 P/Share
|
|
Apr 05
2024
|
James H Stanker Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,675
+20.15%
|
-
|
|
Apr 05
2024
|
Sian Bigora Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
368
-1.69%
|
$736
$2.79 P/Share
|
|
Apr 05
2024
|
Sian Bigora Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,675
+7.13%
|
-
|
|
Apr 05
2024
|
Patrick Lin Chief Business - Strategy Off |
SELL
Payment of exercise price or tax liability
|
Direct |
539
-1.84%
|
$1,078
$2.79 P/Share
|
|
Apr 05
2024
|
Patrick Lin Chief Business - Strategy Off |
BUY
Exercise of conversion of derivative security
|
Direct |
1,675
+5.42%
|
-
|
|
Apr 05
2024
|
David Young Pres. Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
518
-0.64%
|
$1,036
$2.79 P/Share
|
|
Apr 05
2024
|
David Young Pres. Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
1,675
+2.02%
|
-
|
|
Apr 05
2024
|
Wendy Guy Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
368
-3.12%
|
$736
$2.79 P/Share
|
|
Apr 05
2024
|
Wendy Guy Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,675
+12.43%
|
-
|
|
Feb 07
2024
|
David Young Pres. Research & Development |
BUY
Open market or private purchase
|
Direct |
21,000
+20.92%
|
$42,000
$2.45 P/Share
|
|
Feb 06
2024
|
David Young Pres. Research & Development |
BUY
Open market or private purchase
|
Direct |
20,000
+25.51%
|
$40,000
$2.53 P/Share
|
|
Feb 01
2024
|
Patrick Lin Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Direct |
1,500
+5.18%
|
$3,000
$2.4 P/Share
|
|
Jan 31
2024
|
Patrick Lin Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Direct |
2,500
+8.78%
|
$5,000
$2.37 P/Share
|
|
Jan 30
2024
|
George K Ng Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
10,000
+33.33%
|
$20,000
$2.7 P/Share
|
|
Jan 30
2024
|
Justin W Yorke |
BUY
Open market or private purchase
|
Indirect |
8,000
+20.39%
|
$16,000
$2.69 P/Share
|
|
Jan 01
2024
|
David Young Pres. Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
518
-0.64%
|
$1,036
$2.79 P/Share
|
|
Jan 01
2024
|
David Young Pres. Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
1,675
+2.02%
|
-
|
|
Jan 01
2024
|
Patrick Lin Chief Business - Strategy Off |
SELL
Payment of exercise price or tax liability
|
Direct |
539
-1.85%
|
$1,078
$2.79 P/Share
|
|
Jan 01
2024
|
Patrick Lin Chief Business - Strategy Off |
BUY
Exercise of conversion of derivative security
|
Direct |
1,675
+5.43%
|
-
|
|
Jan 01
2024
|
James H Stanker Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
518
-7.8%
|
$1,036
$2.79 P/Share
|
|
Jan 01
2024
|
James H Stanker Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,675
+20.15%
|
-
|
|
Jan 01
2024
|
Wendy Guy Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
368
-3.12%
|
$736
$2.79 P/Share
|
|
Jan 01
2024
|
Wendy Guy Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,675
+12.43%
|
-
|
|
Jan 01
2024
|
Sian Bigora Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
368
-1.69%
|
$736
$2.79 P/Share
|
|
Jan 01
2024
|
Sian Bigora Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,675
+7.13%
|
-
|
|
Nov 21
2023
|
Justin W Yorke |
SELL
Other acquisition or disposition
|
Indirect |
55,267
-10.63%
|
-
|
|
Oct 12
2023
|
Wendy Guy Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,771
+6.8%
|
$0
$0.34 P/Share
|
|
Oct 12
2023
|
Patrick Lin Chief Business - Strategy Off |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+1.05%
|
$0
$0.32 P/Share
|
|
Oct 12
2023
|
George K Ng Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+33.33%
|
$0
$0.25 P/Share
|
|
Oct 12
2023
|
David Young Pres. Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
155,277
+16.82%
|
$0
$0.29 P/Share
|
|
Oct 12
2023
|
Justin W Yorke |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+7.34%
|
$0
$0.3 P/Share
|
|
Oct 12
2023
|
James H Stanker Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+13.13%
|
$0
$0.33 P/Share
|
|
Oct 10
2023
|
Geraldine Pannu |
BUY
Grant, award, or other acquisition
|
Direct |
4,500
+7.24%
|
$0
$0.21 P/Share
|
|
Oct 10
2023
|
Patrick Lin Chief Business - Strategy Off |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+2.86%
|
$0
$0.21 P/Share
|
|
Oct 10
2023
|
David Young Pres. Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
142,000
+18.82%
|
$0
$0.24 P/Share
|
|
Oct 10
2023
|
George K Ng Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
$0
$0.25 P/Share
|
|
Oct 10
2023
|
Justin W Yorke |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+14.68%
|
$0
$0.21 P/Share
|
|
Oct 10
2023
|
James H Stanker Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+21.08%
|
$0
$0.24 P/Share
|
|
Jun 27
2023
|
Justin W Yorke |
BUY
Exercise of conversion of derivative security
|
Direct |
23,636
+29.41%
|
-
|